Related Posts
High end plaintiff’s catastrophic personal injury firm in Philadelphia. We are in need of an experienced paralegal and a legal assistant to work directly with a partner on pre-lit and litigation/trial matters. Majority of case load is medical malpractice. Very competitive salary, health benefits, 401k with match. Email resume with cover letter (including relevant background, why you would be a good fit, and salary requirements) to pbrandes@messalaw.com.
More Posts
What’s the interview process for Counsel roles?
Best beach weekend getaway in the US?
Anyone working for Google can refer me, please?
2019 is to David Boies as 2017 is to Louis CK
Additional Posts in Option Traders & Investing
lol are we just gambling addicts by another name
9/15 Thread (BC):
5/27 Thread (MB):
How you like dem AAPLs?
Puts on RCL?
Any wayfair plays? It’s back up to the $190 mark
5/4 Thread (General):
NOK next get in while ya can homies
New to Fishbowl?
unlock all discussions on Fishbowl.
Functional medicine and psychedelic medicine is the future of all medicine. I like MNMD -
I like MNMD as a second pick. It’s market cap is pretty high to see huge returns. The risk/reward I like more is wesana health. It’s only 2.7 million market cap and has done about just as much as MNMD to get a drug approved by the FDA. It just hasn’t raised as much money so it could run out of funding which is the biggest risk. Have you looked into it at all?
Look at what happened to the cannabis stocks tho. The pain was real for this guy.
I am way more bullish on psychedelics because 30% of people who are depressed don’t respond to antidepressants. Psychs will first target these users. The depression industry is about $15 billion and anxiety market is about $6 billion. There is massive potential here. I can see psychs disrupting both of these markets. There’s way more growth opportunity for psychs compared to cannabis.
It’s all about getting in at the right price